0001209191-11-021312.txt : 20110404 0001209191-11-021312.hdr.sgml : 20110404 20110404203121 ACCESSION NUMBER: 0001209191-11-021312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110331 FILED AS OF DATE: 20110404 DATE AS OF CHANGE: 20110404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRILLO LOPEZ ANTONIO J CENTRAL INDEX KEY: 0001235942 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 11737950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5105976500 MAIL ADDRESS: STREET 1: 2100 POWELL STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-03-31 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001235942 GRILLO LOPEZ ANTONIO J C/O ONYX PHARMACEUTICALS, INC. 249 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2011-03-31 4 A 0 3000 0.00 A 7265 D Stock Option (Right to Buy) 35.18 2011-03-31 4 A 0 5000 0.00 A 2012-03-31 2021-03-31 Common Stock 5000 5000 D Represents a restricted stock award granted to the reporting person. The award vests on the first anniversary of the grant date. /s/ Matthew K. Fust, Attorney-in-fact 2011-04-04